TCL Archive Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says February 19, 1993
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001